O'Shaughnessy Asset Management, LLC Ovid Therapeutics Inc. Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.69 - $3.31 $71,027 - $139,112	-42,028 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.65 - $3.49 $111,374 - $146,677	42,028 New	42,028 $132,000
Q4 2021 Feb 11, 2022	SELL	$3.13 - $3.73 $5,987 - $7,135	-1,913 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$3.31 - $4.04 $612 - $747	185 Added 10.71%	1,913 $6,000
Q2 2020 Aug 13, 2020	BUY	$2.67 - $7.91 $4,613 - $13,668	1,728 New	1,728 $13,000
Q1 2020 May 13, 2020	SELL	$2.03 - $4.35 $10,080 - $21,602	-4,966 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$2.08 - $5.06 $10,329 - $25,127	4,966 New	4,966 $21,000

39M

37.4K

500

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $73.2M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.